Advertisement

Topics

Biotech 2011 Company Profile

04:59 EDT 29th August 2016 | BioPortfolio

Designed to advance the bioiscience industries in the mid-Atlantic region, the Biotech symposium each year attracts top executives from the region's global pharmaceutical, biotechnology, medical device, and diagnostic companies; venture capitalists and other investors; university researchers; university-industry liaison officers; government officials; and support organizations. This must-attend event will feature thought-provoking panel discussions, dynamic plenary sessions, renowned keynote speakers, an Innovation Forum, an Exhibit Hall, and much more.


News Articles [1733 Associated News Articles listed on BioPortfolio]

Figure: Big pharma and big biotech

Mixed bag for PPPs Strategy Big pharma and big biotech Number of PPPs by big pharmas and big biotechs since 2011, including consortia and standard research partnerships. *2016 totals are calculated th...

Biotech of the Week: Mission Therapeutics and a Cambridge Pathway against Cancer

From East to West, this week we say goodbye to Hungary and head up towards Queen Elizabeth II’s United Kingdom. Cambridge, known for its World renowned Academia is where Mission Therapeutics, o...

Celgene, Jounce in immuno-oncology deal

Celgene Corp. (NASDAQ:CELG) obtained options to license multiple immuno-oncology programs from Jounce Therapeutics Inc. (Cambridge, Mass.), including lead candidate JTX-2011.Celgene is to pay Jounce $...

#jobs #lifescience R&D Engineer- Biotech

// MA-Framingham, R&D Engineer- Biotech The Company Our client, a leader in their industry, is seeking an experienced R&D Engineer- Biotech for its manufacturing facility located in Framingh...

#news #biotech Swiss biotech continues to do well

// Despite political disturbances, 2015 was a good year for the biotech scene in Switzerland. Net sales increased by 5.1% to CHF5,133m and 400 additional people found jobs in the sector. As usual, the...

US branded medication prices have doubled since 2011, figures show

The average price of brand-name drugs in the US rose by 16.2% in 2015, with the rise since 2011 now at…

#news #biotech Dermatology biotech Novan goes for $60M IPO

// Dermatology biotech Novan goes for $60M IPO badams Thu, 08/25/2016 – 08:37 from Biotech Stories http://ift.tt/2bqxcg2 Cet article #news #biotech Dermatology biotech Novan goes for $60M IPO es...

Bad News this Week for Biotech Deals? News from Biospace on Deals week of 3/7/2016

Bad News this Week for Biotech Deals?   Stephen J. Williams, Ph.D.; Curator   Last week in biotech ( 3/7-3/11/2016) had a plethora of disappointing stories related to biotech drug development an...

Drugs and Medications [151 Associated Drugs and Medications listed on BioPortfolio]

Ocufresh [Taiwan Biotech Co, Ltd]

Minidrops [Taiwan Biotech Co, Ltd]

Iman time control all day moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Iman time control oil free moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Stelara [Janssen Biotech, Inc.]

These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) Injection, for subcutaneous useIn...

PubMed Articles [468 Associated PubMed Articles listed on BioPortfolio]

Neuro-oncology biotech industry progress report.

The Brain Tumor Biotech Center at the Feinstein Institute for Medical Research, in collaboration with Voices Against Brain Cancer hosted The Brain Tumor Biotech Summit at in New York City in June 2015...

Response to proposed research to reverse brain death: more than regulatory failure.

In early May 2016, reports of a bizarre study to attempt a reversal of brain death made the headlines, but there was not even a squeak from the authorities. The "Reanima Project" is a collaboration be...

Erratum: When biotech goes bad.

First-quarter biotech job picture.

Second-quarter biotech job picture.

Clinical Trials [140 Associated Clinical Trials listed on BioPortfolio]

A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization

This is a multi-center study to evaluate the effects of DR-2011 compared to a progesterone gel in women undergoing in vitro fertilization with fresh eggs. The overall study duration will b...

Comparison of DR-2011 to a Progesterone Vaginal Gel for Luteal Phase Replacement

This is a single-center, open-label, randomized, active-controlled study to compare DR-2011 to progesterone vaginal gel for luteal phase replacement.

A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects

The purpose of this single-centre, randomized, double-blind, parallel control, phase 3 study is to evaluate the safety and immunogenicity of a rabies vaccine (Vero Cell) for human use in h...

Flu Vaccine Study in Neuromuscular Patients 2011

The purpose of the study is to compare the immune response of two different injection methods (Intramuscular V.S. Subcutaneous) of the 2011-2012 seasonal Influenza (Flu) vaccine among pati...

Study to Evaluate the Immune Response and the Safety of Fluarix TM/ Influsplit SSW® 2010/2011 or Pandemrix TM

The aim of this study is to evaluate the immune response and the safety of one injection of FluarixTM/ Influsplit SSW® 2010/2011 or Pandemrix TM in subjects who had received a single Pand...

Companies [1198 Associated Companies listed on BioPortfolio]

PBS Biotech Inc.

PBS Biotech, based in Camarillo, California, has developed the new generation PBS Single Use Bioreactors with patented unique Air-wheel™ mixing technology. PBS Biotech is one...

Hookipa Biotech AG

Hookipa Biotech, founded in Vienna, Austria in summer 2011, develops a new class of innovative prophylactic and therapeutic vaccines based on its proprietary Vaxwave® technology. The Vaxwave&r...

Biotech 2011

Designed to advance the bioiscience industries in the mid-Atlantic region, the Biotech symposium each year attracts top executives from the region's global pharmaceutical, biotech...

BioTech Umeå

The Biotech industry stimulates growth and creates new job opportunities in Sweden. The city of Umeå hosts first-rate biotech research. BioTech Umeå is a driving force helping the industry as well a...

Rhein Biotech N.V.

Rhein Biotech is a globally active biotech company and the world's third largest hepatitis B vaccine manufacturer. Berna Biotech, a fully integrated vaccine focused biotechnology company acquired 92.2...

More Information about "Biotech 2011" on BioPortfolio

We have published hundreds of Biotech 2011 news stories on BioPortfolio along with dozens of Biotech 2011 Clinical Trials and PubMed Articles about Biotech 2011 for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biotech 2011 Companies in our database. You can also find out about relevant Biotech 2011 Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...


Corporate Database Quicklinks



Searches Linking to this Company Record